Wegovy 0.25mg Injection
Available Pack Sizes
Free Shipping
Order above $200.00
Worldwide Delivery
8-10 Business Days
24/7 Support
Solve your queries
- 100% Genuine Medicines
- Secure International Logistics
- Secure Payment
- Authentic Pharmaceutical Supplier
How to Order from Medionix Pharma
Add Products
Browse our medicines and add the required products to your cart.
Add Products to Cart
Order Method
Place your order easily through WhatsApp or Email support.
Choose Your Ordering Method
Share Details
Provide your delivery address and contact information.
Share Delivery & Prescription Details
Order Dispatched
Your order is packed securely and shipped worldwide.
Order Confirmation & Dispatch
Wegovy 0.25mg Injection
contains Semaglutide 0.25mg in a pre-filled auto-injector pen for once-weekly subcutaneous use. This is the starting dose of Wegovy, a GLP-1 receptor agonist specifically approved for chronic weight management in adults with a BMI ≥30 kg/m² or ≥27 kg/m² with at least one weight-related comorbidity. The 0.25mg initiation dose allows the body to adapt to semaglutide over the first 4 weeks before escalation.
Benefits:
- Initiates GLP-1-mediated weight management with a low-tolerance dose
- Minimises early gastrointestinal side effects during the titration period
- Sets the foundation for the progressive dose escalation to 2.4mg
- Approved specifically for chronic weight management in adults with obesity
- Once-weekly injection for long-term, convenient treatment
How It Works:
Wegovy uses the same semaglutide molecule as Ozempic but follows a slower dose-escalation schedule reaching a higher maximum dose of 2.4mg, resulting in substantially greater weight loss. At 0.25mg, the drug begins GLP-1 receptor activation, mildly suppressing appetite and priming the metabolic pathways that will produce significant weight reduction at higher doses.
Dosage and Administration:
Inject 0.25mg subcutaneously once weekly for 4 weeks. Administer into the abdomen, thigh, or outer upper arm at any time of day, with or without food. Rotate injection sites within the same body region. After 4 weeks, escalate to 0.5mg as directed by the prescriber. Never skip the initiation phase.
Side Effects:
Common: nausea, diarrhoea, constipation, vomiting, abdominal pain, headache. Injection-site: mild pain or redness. Uncommon: fatigue, dizziness, increased heart rate. Serious: pancreatitis, cholelithiasis, suicidal ideation (monitor mental health), diabetic retinopathy.
Precautions:
Contraindicated in personal or family history of medullary thyroid carcinoma or MEN2. Monitor patients for depression or mood changes. Use with caution in patients with a history of gallbladder disease. Not suitable for use in type 1 diabetes.
Wegovy Dosage Comparison Guide
| Strength | Best For | Onset | Duration | Link |
|---|---|---|---|---|
| 0.25mg | Lower strength option | 2–4 wks | Weekly | Current |
| 0.5mg | Standard strength option | 2–4 wks | Weekly | View → |
| 1mg | Popular strength option | 2–4 wks | Weekly | View → |
| 1.7mg | Higher strength option | 2–4 wks | Weekly | View → |
| 2.4mg | Maximum strength variant | 2–4 wks | Weekly | View → |
* Always consult your doctor before changing your dosage. This information is for educational reference only.
Frequently Asked Questions
Q1: What is Wegovy 0.25mg used for?
Wegovy 0.25mg is the starting dose for chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related health condition such as hypertension, type 2 diabetes, or dyslipidaemia.
Q2: How is Wegovy different from Ozempic?
Both contain semaglutide, but Wegovy is approved for weight management and follows a dose-escalation schedule reaching 2.4mg, whereas Ozempic is approved for type 2 diabetes with a maximum dose of 1mg. The higher Wegovy dose produces significantly greater weight loss.
Q3: How long do I stay on 0.25mg before escalating?
The 0.25mg dose is used for exactly 4 weeks as the initiation phase. After that, your prescriber will advance you to 0.5mg, continuing the escalation schedule toward the 2.4mg maintenance dose over approximately 16 weeks.
Q4: Does Wegovy 0.25mg cause weight loss?
At the 0.25mg initiation dose, weight loss is minimal. This dose exists purely to improve tolerability; the therapeutic weight-loss doses begin at 1mg and above in the escalation schedule.
Q5: Can I use Wegovy if I have type 2 diabetes?
Yes. Wegovy is suitable for patients with type 2 diabetes and obesity. It provides glycaemic benefit in addition to weight loss. Your diabetes medications may need adjustment as blood sugar improves.
Q6: Where on the body can I inject Wegovy?
Inject into the lower abdomen (at least 2 inches from the navel), front of the thigh, or outer upper arm. Rotate among these sites each week to prevent lipohypertrophy at any single location.
Q7: What if I experience severe nausea on Wegovy 0.25mg?
Mild to moderate nausea is expected during initiation. Eating smaller, lower-fat meals and avoiding lying down after eating can help. If nausea is severe or persistent, contact your prescriber before escalating the dose.
Q8: Can I drink alcohol while on Wegovy?
Moderate alcohol consumption is generally not contraindicated, but alcohol can worsen nausea and affect blood sugar. Patients with obesity-related liver disease should avoid alcohol entirely. Discuss with your prescriber.
Q9: Is Wegovy safe for patients with heart disease?
The SELECT cardiovascular outcomes trial demonstrated that semaglutide 2.4mg reduced MACE by 20% in overweight/obese adults with established cardiovascular disease and without diabetes. Wegovy is considered cardioprotective in this population.
Q10: Do I need a prescription for Wegovy?
Yes. Wegovy is a prescription-only medication. It requires evaluation by a healthcare provider to confirm eligibility (BMI criteria and comorbidities) and ongoing monitoring during treatment.
Customer Reviews
Dr. Maria Santos
Australia · 3 weeks ago
“Good quality product. Shipping was fast and handled with care. Would recommend for professional hospital procurement.”
Michael K.
USA · 2 months ago
“Fast international shipping and professional packaging. Product was exactly as described. Highly recommend this supplier.”
Dr. James Wilson
USA · 1 week ago
“Excellent product quality. Arrived well-packaged with proper cold chain maintained throughout transit. Will order again.”
Priya Sharma
India · 1 month ago
“Prompt response from the team and smooth ordering process. Medicine arrived in original sealed packaging as expected.”
FirstCare Clinic
Canada · 3 months ago
“Good value for bulk procurement orders. Communication was clear and the shipment arrived within the estimated timeframe.”
Related Products
Disclaimer
The information provided on Medionix Pharma is intended for general informational purposes only. It should not be considered as medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before using any medication or starting any treatment.
Medionix Pharma does not encourage self-medication. Customers are responsible for ensuring that purchases comply with local laws and prescription requirements in their country. If you have any questions or concerns regarding the content on our website, please contact us at sales@medionixpharma.com.